Clinical trial
Early Screening of Colorectal Cancer Based on Plasma Multi-omics Combining With Artificial Intelligence-a Multi-center, Prospective Study
NCT05587452 is registered in ClinicalTrials.gov with Cancer Institute and Hospital, Chinese Academy of Medical Sciences as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Early Screening of Colorectal Cancer Based on Plasma Multi-omics Combining With Artificial Intelligence-a Multi-center, Prospective Study
- Lead sponsor
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- May 1, 2022
- Completion date
- May 1, 2025
- Enrollment
- 950 (estimated)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.
colorectal adenoma, colorectal cancer